GEC-ESTRO recommendations
A first target related to the extent of
GTV
at diagnosis
:
intermediate dose: 60 Gy
Intermediate-risk CTV
▬►
isodose envelope prescription
A second target related to the extent of
GTV
at time of BT
:
3
high dose: 85 Gy
High-risk CTV
▬►
Point A prescription




